We are live on ! Find out more
DP

DSAM Partners Portfolio holdings

AUM $176M
1-Year Est. Return 83.78%
This Fund
S&P 500
This Quarter Est. Return
+17.01%
1 Year Est. Return
+83.78%
3 Year Est. Return
+343.2%
5 Year Est. Return
+1,202.92%
10 Year Est. Return
AUM
$539M
AUM Growth
-$315M
Cap. Flow
-$367M
Cap. Flow %
-68.06%
Top 10 Hldgs %
61.65%
Holding
78
New
20
Increased
8
Reduced
19
Closed
31

Top Sells

Rank Stock Value
1
CARR icon
Carrier Global
CARR
+$40.1M
2
MP icon
MP Materials
MP
+$32.2M
3
CLVT icon
Clarivate
CLVT
+$29.7M
4
BJ icon
BJs Wholesale Club
BJ
+$27.9M
5
AMZN icon
Amazon
AMZN
+$25.6M

Sector Composition

Rank Sector Weight
1 Technology 30.52%
2 Industrials 18.68%
3 Consumer Discretionary 11.62%
4 Energy 10.51%
5 Healthcare 8.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KRYS icon
26
Krystal Biotech
KRYS
$10.5B
$5.41M 1%
70,274
-17,334
-20% -$1.26M
XOS icon
27
Xos
XOS
$27.8M
$5.22M 0.97%
+17,541
New +$5.7M
KRON
28
DELISTED
Kronos Bio
KRON
$5.19M 0.96%
177,426
-22,670
-11% -$664K
BODI icon
29
The Beachbody Company
BODI
$78.4M
$4.98M 0.92%
+9,846
New +$5.54M
BBIO icon
30
BridgeBio Pharma
BBIO
$16.6B
$4.95M 0.92%
80,384
-19,553
-20% -$1.28M
VMC icon
31
Vulcan Materials
VMC
$37.6B
$4.89M 0.91%
28,956
-3,701
-11% -$600K
HRTX icon
32
Heron Therapeutics
HRTX
$92.7M
$4.59M 0.85%
283,415
-67,743
-19% -$1.21M
MELI icon
33
Mercado Libre
MELI
$94.9B
$4.12M 0.76%
2,800
+900
+47% +$1.53M
EPAM icon
34
EPAM Systems
EPAM
$5.25B
$3.17M 0.59%
8,000
+3,000
+60% +$1.1M
RBA icon
35
RB Global
RBA
$21.8B
$2.93M 0.54%
+50,000
New +$2.93M
CLDX icon
36
Celldex Therapeutics
CLDX
$2.81B
$2.8M 0.52%
135,907
-34,093
-20% -$783K
IOVA icon
37
Iovance Biotherapeutics
IOVA
$2.12B
$2.58M 0.48%
81,627
-20,530
-20% -$851K
EXP icon
38
Eagle Materials
EXP
$6.84B
$2.5M 0.46%
18,584
-2,375
-11% -$288K
ALUS
39
DELISTED
Alussa Energy Acquisition Corp
ALUS
$2.37M 0.44%
+237,021
New +$2.65M
SUM
40
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$2.32M 0.43%
84,310
-10,773
-11% -$271K
IMTX icon
41
Immatics
IMTX
$1.15B
$1.72M 0.32%
152,990
+78,254
+105% +$888K
NEXI
42
DELISTED
NexImmune, Inc. Common Stock
NEXI
$1.71M 0.32%
+3,580
New +$1.95M
JD icon
43
JD.com
JD
$42.8B
$1.69M 0.31%
+20,000
New +$1.83M
OPCH icon
44
Option Care Health
OPCH
$3.53B
$1.32M 0.25%
+74,583
New +$1.4M
APLT
45
DELISTED
Applied Therapeutics
APLT
$1.26M 0.23%
+67,125
New +$1.45M
AFIB
46
DELISTED
Acutus Medical Inc
AFIB
$961K 0.18%
71,848
+18,923
+36% +$426K
ARYD
47
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$209K 0.04%
+20,000
New +$216K
AEVA
48
Aeva Technologies
AEVA
$995M
-241,122
Closed -$17.5M
AMZN icon
49
Amazon
AMZN
$2.49T
-157,380
Closed -$25.6M
BJ icon
50
BJs Wholesale Club
BJ
$12.4B
-747,434
Closed -$27.9M

Similar funds

DSAM Partners's Q1 2021 Portfolio in Review

As of Q1 2021, DSAM Partners held 78 positions worth $539M, down 37% from $854M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

DSAM Partners withdrew a net $367M in Q1 2021, closing 31 positions and reducing 19 holdings. Its most notable exit was MP Materials, an estimated $32.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 31% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, DSAM Partners opened a new position in Occidental Petroleum worth $20.7M.

  • DSAM Partners's largest Q1 2021 buy was Occidental Petroleum: 776,003 shares worth $20.7M.
  • DSAM Partners added most to Vontier in Q1 2021, an estimated $14.7M increase.
  • DSAM Partners's biggest Q1 2021 reduction was Carrier Global, cutting an estimated $40.1M.
  • DSAM Partners fully exited MP Materials in Q1 2021, selling an estimated $32.2M.
  • DSAM Partners's ten largest holdings make up 62% of its $539M portfolio in Q1 2021.
  • DSAM Partners opened 20 new positions and closed 31 in Q1 2021.
  • DSAM Partners's portfolio value fell 37% quarter-over-quarter to $539M.

Based on DSAM Partners's 13F filing for Q1 2021, filed 17 May 2021.